Advances in predictive hypoglycemia-minimizing technology from Animas-JDRF collaboration

Presented at the American Diabetes Association Scientific Sessions

2014-06-16

(Press-News.org) CHESTERBROOK, Pennsylvania, June 16, 2014 –Animas Corporation today shared encouraging results from its predictive hypoglycemia-minimizing algorithm in development. Data from a clinical feasibility study demonstrated that the algorithm was capable of helping maintain glucose above hypoglycemic levels an average of 99.1 percent of the time for the 12 participants investigated, all of whom were adults with type 1 diabetes. The study was conducted by Animas in collaboration with industry, academia and JDRF as part of an effort to advance the development of a predictive blood glucose-regulating system for patients with type 1 diabetes.

The investigational device, comprised of an Animas insulin pump, Dexcom's G4™ PLATINUM continuous glucose monitor (CGM) system and predictive algorithm, dosed basal insulin automatically based on participants' CGM values to minimize exposure to hypoglycemic levels (glucose END

ELSE PRESS RELEASES FROM THIS DATE:

Arctic warming linked to fewer European and US cold weather extremes, new study shows

2014-06-15

Climate change is unlikely to lead to more days of extreme cold, similar to those that gripped the USA in a deep freeze last winter, new research has shown. The Arctic amplification phenomenon refers to the faster rate of warming in the Arctic compared to places further south. It is this phenomenon that has been linked to a spike in the number of severe cold spells experienced in recent years over Europe and North America. However, new research by University of Exeter expert Dr James Screen has shown that Arctic amplification has actually reduced the risk of cold extremes ...

Parasitic worms of pigs could provide new treatments of human diseases

2014-06-15

New treatments for inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, diabetes and autism could be on the horizon, after a global University of Melbourne – lead study successfully mapped the genes of a parasitic worm in pigs. Lead researcher, Dr Aaron Jex, Faculty of Veterinary Science, said, "We know that humans infected with the harmless, 'pig whipworm' can have significantly reduced symptoms linked to autoimmune diseases. And now we have the genetic sequence of the worm, it opens the door to future human drug designs and treatment." Although the ...

Melting and refreezing of deep Greenland ice speeds flow to sea, study says

2014-06-15

Beneath the barren whiteness of Greenland, a mysterious world has popped into view. Using ice-penetrating radar, researchers have discovered ragged blocks of ice as tall as city skyscrapers and as wide as the island of Manhattan at the very bottom of the ice sheet, apparently formed as water beneath the ice refreezes and warps the surrounding ice upwards. The newly revealed forms may help scientists understand more about how ice sheets behave and how they will respond to a warming climate. The results are published in the latest issue of Nature Geoscience. "We see ...

Exploring a parasitic tunnel boring machine

2014-06-15

Researchers have deduced essential biological and genetic information from the genome sequence of the whipworm, an intestinal parasitic worm that infects hundreds of millions of people in developing countries. This information acts as the foundation for the development of new strategies and treatments against this debilitating parasite. The whipworm is one of three types of soil-transmitted parasitic worms that collectively infect nearly two billion people. While infections often result in mild disease they may also lead to serious and long-term damage such as malnutrition, ...

Understanding the unique nature of children's bodies and brains

2014-06-15

June 15, 2014 (San Francisco) – With the increase in childhood obesity and the associated increase in type 2 diabetes among children and adolescents, there is growing interest in how children's bodies process the foods they eat and how obesity and diabetes begin to develop at early ages. Two studies presented at the American Diabetes Association's 74th Scientific Sessions® help to shed light on this topic. One study, by researchers at the Yale School of Medicine, compared how the brains of adolescents and adults differed in their response to ingestion of a glucose drink. ...

'Disappointed' researchers find lack of political voices on Twitter

2014-06-15

ITHACA, N.Y. – Social scientists' analysis of 290,119,348 tweets from 193,522 "politically engaged" Twitter users during the 2012 presidential campaign conventions and debates found little creative thinking, and a slavish blitz of retweeting "elites" like @billmaher and @seanhannity, according to a new study. "Frankly, we're rather disappointed," says Cornell University's Drew Margolin. "Social media has so much potential to improve the diversity of voices and quality of exchanges in political discussion by giving individuals the technological capability to compete with ...

Emotional contagion sweeps Facebook, finds new study

2014-06-15

ITHACA, N.Y. – When it hasn't been your day – your week, your month, or even your year – it might be time to turn to Facebook friends for a little positive reinforcement. According to a new study by social scientists at Cornell University, the University of California, San Francisco (UCSF), and Facebook, emotions can spread among users of online social networks. The researchers reduced the amount of either positive or negative stories that appeared in the news feed of 689,003 randomly selected Facebook users, and found that the so-called "emotional contagion" effect worked ...

Fasting reduces cholesterol levels in prediabetic people over extended period of time

2014-06-14

For prediabetics, many interventions focus on lifestyle changes and weight loss, but new research on periodic fasting has identified a biological process in the body that converts bad cholesterol in fat cells to energy, thus combating diabetes risk factors. Researchers at the Intermountain Heart Institute at Intermountain Medical Center in Murray, Utah, noticed that after 10 to 12 hours of time fasting, the body starts scavenging for other sources of energy throughout the body to sustain itself. The body pulls LDL (bad) cholesterol from the fat cells and uses it as energy. "Fasting ...

Late-breaking observational data show patients with type 2 diabetes taking JANUVIA® (sitagliptin) and metformin initiated insulin therapy at a slower rate compared to patients taking a sulfonylurea an

2014-06-14

WHITEHOUSE STATION, N.J., June 14, 2014 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a late-breaking observational study that assessed the differences in time to initiation of insulin use and the proportion of the population initiating insulin among patients with type 2 diabetes taking the combination of JANUVIA® (sitagliptin) and metformin, and patients taking the combination of a sulfonylurea and metformin. In this study, patients treated with a combination of JANUVIA and metformin initiated insulin therapy at a ...

New post-hoc analysis shows patients with type 2 diabetes undergoing intensification of insulin therapy experienced less nighttime hypoglycemia while being treated with Januvia (Sitagliptin) compared

2014-06-14

WHITEHOUSE STATION, N.J., June 14, 2014 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc analysis showing that patients with type 2 diabetes having treatment intensified with insulin glargine therapy while also being treated with JANUVIA® (sitagliptin) 100 mg once-daily had a lower incidence of nighttime (nocturnal) hypoglycemia compared to patients also receiving placebo. Results were presented at the American Diabetes Association 74th Scientific Sessions. "Type 2 diabetes is a progressive disease, so that ...

Advances in predictive hypoglycemia-minimizing technology from Animas-JDRF collaboration

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: